Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cetrotide 0.25mg Injection

Prescription Icon
Prescription Required

Marketer

Merck Ltd

Salt Composition

Cetrorelix (0.25mg)

Overview Cetrotide 0.25mg Injection

Ganirelix 0.25mg Injection, a gonadotropin-releasing hormone antagonist, aids female infertility treatment. It prevents premature egg release, thereby controlling ovulation. Administered subcutaneously by a healthcare professional, self-injection is strictly prohibited. Your doctor or nurse will provide guidance on proper home injection techniques. Dosage and frequency are determined by your individual needs and condition; your physician will tailor the treatment to optimize your response. Continue using this medication as prescribed. Common side effects include injection site reactions (redness, itching, swelling), nausea, and vomiting. Rotate injection sites (e.g., the abdomen) daily to minimize irritation. Report dizziness, fainting, abdominal pain, or persistent vomiting immediately. Before commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or if you are breastfeeding. Always disclose all other medications you are currently using, as interactions may affect the efficacy or action of Ganirelix.

Primary Ingredients of Cetrotide 0.25mg Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Cetrotide 0.25mg Injection

Inability to conceive in women

Major Benefits of Cetrotide 0.25mg Injection:

Administering this medication requires the assistance of your doctor or nurse; self-medication is strictly prohibited.

Common Side effects of Cetrotide 0.25mg Injection:

  • Nausea
  • Ovarian hyperstimulation syndrome
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Irritation
  • Vomiting
  • Lower abdominal pain

How to use Cetrotide 0.25mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Cetrotide 0.25mg Injection works:

During infertility treatment in women, premature egg release may occur before the eggs are mature enough for fertilization. Cetrotide 0.25mg Injection inhibits a natural hormone, thus preventing premature ovarian egg expulsion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining alcohol and Cetrotide 0.25mg Injection. Seek medical advice before doing so.

PregnancyPregnancyUNSAFE

The use of Cetrotide 0.25mg Injection is strongly contraindicated in pregnancy. Pregnant women should consult their physician, as research in animal models and human studies has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Using Cetrotide 0.25mg Injection while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by a 0.25mg injection of Cetrotide.

KidneyKidneyCAUTION

Patients with kidney impairment should use Cetrotide 0.25mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Cetrotide 0.25mg Injection is contraindicated in those with severe kidney disease.

LiverLiverCAUTION

Individuals with hepatic impairment should use Cetrotide 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Cetrotide 0.25mg Injection :

Should you forget a Cetrotide 0.25mg Injection, seek your physician's advice.

Facts to Know About Cetrotide 0.25mg Injection

LabelValue
Chemical Type Peptide chains
Developing Habits No.
Type of Therapy Endocrine Signals
Behavior Class GnRH receptor blockers

FAQs on Cetrotide 0.25mg Injection

Ganirelix 0.25mg (Cetrotide) Injection is used in assisted reproductive technologies to prevent premature egg release. This injectable medication blocks luteinizing hormone (LH), allowing for optimal egg development before ovulation. It's typically administered alongside other fertility medications.
Administered only by healthcare professionals in hospitals or clinics via injection, patients receive regular monitoring of follicular development. Treatment length varies based on individual ovarian response.
Local skin redness (with or without swelling) is the most frequent side effect. Headache and nausea may also occur. These are typically temporary, but persistent symptoms warrant medical attention. Rarely, more serious complications such as ovarian hyperstimulation syndrome (OHSS), multiple births, or birth defects may be linked to this medication.
Cetrotide 0.25mg Injectio...
2,267
MRP 2,624
13% off